BRINGING EVIDENCE CLOSER TO HEALTHCARE DECISIONS

MANAGING DIRECTOR

Juan Gabriel Gay Molina, M.D.

  • General surgeon graduated from Universidad Anáhuac.
  • Master of Public Health from the University of London (LSHTM).
  • Master of Health Policy and Economics from the London School of Economics and Political Science.

Experience

General Director of TIS dedicated to the advising of projects of health development and economic evaluation. Juan has an extensive background in the analysis and development of economic evaluation studies in health. He has worked for the federal government of Mexico as Coordinator of Advisors to the Secretary of the General Health Council and as Deputy Director of Sustainability of the General Directorate of Health Planning and Development of the Ministry of Health. He has also developed research and analysis projects for the OECD (Organization for Economic Cooperation and Development) and the School of Hygiene and Tropical Medicine at the University of London.

DIRECTOR OF HEALTH SYSTEMS

Adrián Dávila, MSc.

  • Economist from the Instituto Tecnológico Autónomo de México (ITAM)
  • Master of Health Economics from the University of York, United Kingdom

Experience

Economist with a Master of Health Economics with 17 years of experience in the public sector and 5 years in the pharmaceutical sector. Experience in public policy evaluation, improvement and monitoring of processes and government relations with federal, state, decentralized institutions and private and social organizations. Skills in economic evaluation of health technologies and market access strategies. Experience as a consultant and instructor in projects and courses in health economics, economic evaluation and insurance.

Kyla Jones, MSc.

Senior Consultant, Health Economics

Bachelor of International Studies from York University (Canada), Master of International Health Policy from the London School of Economics and Political Science. Experience in modelling access to markets, and inequities in health.

Raquel Almazán, MSc.

Senior Consultant, Access

Bachelor of Science and Information Technology.
Master of Health Services and Hospital Administration.
Experience in processes of Mexican implementation of communication and marketing strategies.

Marc Valls Pallejà, MSc.

Senior Consultant, Health Economics

Bachelor in Business Administration and Management from Pompeu Fabra University (UPF). Master of Health Economics from the Barcelona Graduate School of Economics. Experience in modelling public health and prevention (OECD).

Leticia López Cuapio, BSc.

Senior analyst

Degree in Economics from the Universidad Iberoamericana. Specialist in public health, social determinants of health, the elderly and chronic diseases, with experience in modelling pharmaceutical products and medical devices, systematic reviews and analysis of data and information. Health Sector and implementation of communication and marketing strategies.

Jessica Torres, BSc.

Junior Analyst

Degree in Economics from the Universidad Nacional Autónoma de México (UNAM). Experience in research, database management, development of economic evaluation models, information analysis, systematic reviews, costs analysis and writing of documents or reports.

Mariana Osorio, BSc.

Senior analyst

Degree in Economics from the Instituto Tecnológico Autónomo de México (ITAM). Experience in evaluation of clinical and economic evidence, health economic modeling, and impact evaluations for the public health sector and knowledge in indicators of the health sector and analysis of social policies.

Celtzin Bonilla, BSc.

Junior Analyst

Degree in Economics from the Universidad Nacional Autónoma de México (UNAM). Experience in systematic reviews of clinical and economic literature, search of statistical data for the construction of economic evaluations and writing of economic reports.

Ameyalli Ramos, M.D.

Medical Analyst

Physician from the Universidad Nacional Autónoma de México (UNAM). Experience in hospital practice and medical teaching in a private institution, as well as preparation in the field of Clinical Pharmacology.